Dog Immune-Mediated Thrombocytopenia Diagnosis and Care

Immune-mediated thrombocytopenia causes dangerously low platelet counts in dogs, requiring rapid diagnosis and immunosuppression to prevent life-threatening bleeding.

Key Facts

IMT is the most common immune-mediated platelet disorder in dogs, occurring when antibodies destroy platelets
American Cocker Spaniels, Old English Sheepdogs, and Poodles have elevated risk
Clinical signs include petechiae (pinpoint hemorrhages in skin), bruising, nosebleeds, and blood in urine or stool
Platelet counts below 30,000/uL create significant spontaneous bleeding risk
Diagnosis requires ruling out infectious, drug-induced, and neoplastic causes of low platelets
Prednisone is the first-line immunosuppressive; additional agents are added in refractory cases
Vincristine or human IVIG can rapidly boost platelet counts in severe bleeding cases

Welfare Considerations

IMT causes bleeding into tissues that is painful and frightening. Severe cases with platelet counts below 10,000 risk internal hemorrhage and death. Dogs on high-dose steroids for treatment experience significant side effects including increased thirst, appetite, and urination. Monitoring for bleeding signs and medication side effects throughout treatment requires close owner vigilance.

What You Can Do

Seek emergency evaluation for any dog with unusual bruising, petechiae, or unexplained bleeding
Restrict activity strictly during treatment to minimize trauma-induced bleeding risk
Complete the full steroid taper as directed - premature dose reduction commonly causes relapse
Monitor for medication side effects and report significant changes to your vet
Join IMT owner support communities to share management experiences